Drug CombinationsDrug Therapy, CombinationDrug SynergismDrug InteractionsPharmaceutical PreparationsDose-Response Relationship, DrugDrug-Related Side Effects and Adverse ReactionsAntineoplastic AgentsDrug Screening Assays, AntitumorDrug ResistanceAntimalarialsDrug Evaluation, PreclinicalChemistry, PharmaceuticalDrug Resistance, MultipleDrug CarriersCell Line, TumorDelayed-Action PreparationsDrug Delivery SystemsDoxorubicinAntihypertensive AgentsAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, ViralTreatment OutcomeDrug Resistance, NeoplasmMicrobial Sensitivity TestsCell SurvivalTime FactorsProguanilAnti-Bacterial AgentsMethenamineModels, BiologicalAlgorithmsP-GlycoproteinDapsoneSolubilityArtemisininsDrug TherapyTumor Cells, CulturedAtovaquoneMethylthioinosineCyclopentolateDrug AntagonismTropicamideKineticsCellophaneRandomized Controlled Trials as TopicSulfamethoxazoleMutationPyrimethamineMefloquineInhibitory Concentration 50FloxuridineSulfadoxineCisplatinPyrazinesReproducibility of ResultsMolecular Targeted TherapyRifampinNanoconjugatesAmodiaquineXenograft Model Antitumor AssaysAmikacinChloroquinePhentermineFluorouracilSesquiterpenesBoronic AcidsNaphthoquinonesAntifungal AgentsApoptosisFluorenesPyrimidinesDeoxycytidinePiperazinesNiacinamideAntitubercular AgentsPlasmodium falciparumPharmacologyDrug Administration ScheduleTrimethoprimDrug DesignSystems BiologyNeoplasmsAmphotericin BAnti-HIV AgentsParasitic Sensitivity TestsVincristinePhenylurea CompoundsCytarabineQuinolinesMalaria, FalciparumMedetomidineQuinazolinesPaclitaxelClinical Trials, Phase I as TopicNitroimidazolesAntiprotozoal AgentsDrug DiscoveryBenzenesulfonatesClinical Trials as Topic